--- title: "002749.SZ (002749.SZ) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/002749.SZ/news.md" symbol: "002749.SZ" name: "002749.SZ" parent: "https://longbridge.com/en/quote/002749.SZ.md" datetime: "2026-05-21T09:46:47.787Z" locales: - [en](https://longbridge.com/en/quote/002749.SZ/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/002749.SZ/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/002749.SZ/news.md) --- # 002749.SZ (002749.SZ) — Related News ### [Taiwan stock market hits a historic high, GGAC and Taiwan Cement expand production, MuDe Technology reports impressive revenue, ETF market attracts investors' attention](https://longbridge.com/en/news/285054201.md) *2026-05-04T10:00:30.000Z* > Taiwan's stock market hits a historical high, GGAC and Taiwan Cement actively expand production, MuDe Technology sees st ### [The growth potential of the biotechnology and environmental protection industries is significant, with the market focusing on inflation and technology stock dynamics](https://longbridge.com/en/news/285052631.md) *2026-05-04T09:50:03.000Z* > The biotechnology and environmental protection industries show significant growth potential, with the market focusing on ### [GGAC's production doubling plan has been launched, and Line 2 has joined the ranks of international manufacturers for collaborative production](https://longbridge.com/en/news/285034491.md) *2026-05-04T06:21:06.000Z* > GGAC (4142) announced the launch of its second automated filling and packaging line, which has passed the GMP review by ### [GGAC: Net profit in the first quarter of 2026 was 60.1307 million yuan, a year-on-year decrease of 23.50%](https://longbridge.com/en/news/283141554.md) *2026-04-17T12:09:18.000Z* > GGAC announced that its revenue for the first quarter of 2026 was 380 million yuan, a year-on-year decrease of 1.24%; ne ### [Market confidence rebounds: Biotech and tech stocks show strong recovery, geopolitical factors influence capital dynamics](https://longbridge.com/en/news/282775440.md) *2026-04-15T03:05:04.000Z* > Market confidence in biotech and technology stocks is recovering, with Shenghua Technology signing a 500 million investm ### [GGAC's third filling line has passed GMP factory inspection, with an estimated annual production capacity of 4 million doses](https://longbridge.com/en/news/282772126.md) *2026-04-15T02:31:55.000Z* > Kuo Kuang Biotechnology (4142-TW) announced that its third automated sterile filling line has passed the GMP inspection, ### [In the first quarter, the Financial Supervisory Commission imposed fines totaling NT$22.38 million, a decrease of 63% in both the amount and number of penalties](https://longbridge.com/en/news/282057197.md) *2026-04-08T14:20:51.000Z* > The Financial Supervisory Commission announced 69 penalties against the financial sector and listed companies in the fir ### [Exclusive / Taishin and Yuanta Securities merger confirmed, with Chen Liguo as the general manager and Guo Jiahong as the dedicated vice chairman](https://longbridge.com/en/news/281712291.md) *2026-04-05T13:55:06.000Z* > Taiwan Shin Kong Securities and Hsinchu Securities will merge, and the board of directors will approve Chen Liguo's reap ### [Taiwan stock market dynamics: Biotech stocks surged strongly, paper stocks pulled back, and the increase in airline fuel surcharges affected ticket prices](https://longbridge.com/en/news/281305578.md) *2026-04-01T05:20:07.000Z* > Taiwan's stock market shows strong gains in biotech stocks, while paper stocks experience a pullback, and the increase i ### [ GGAC's subsidiary Antelope's enterovirus vaccine has obtained drug approval in Macau, rising back to the annual line](https://longbridge.com/en/news/281305187.md) *2026-04-01T05:11:38.000Z* > GGAC's subsidiary Antelope's enterovirus vaccine EnVAX-A71 has obtained drug approval in Macau, driving GGAC's stock pri